| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $884.2M | $963.8M | $1.07B |
| YoY Revenue Growth % | -8.3% | -9.6% | — |
| Gross Profit | $343.0M | $397.8M | — |
| Gross Margin % | 38.8% | 41.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $111.5M | $146.6M | $245.7M |
| Operating Margin % | 12.6% | 15.2% | 23.0% |
| Net Income (GAAP) | $53.8M | $70.4M | $135.7M |
| EBITDA (Normalized) | $131.9M | $162.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $139.5M | $154.0M | $215.0M |
| Capital Expenditures (CapEx) | $25.5M | $20.1M | — |
| Free Cash Flow (FCF) | $114.0M | $133.9M | $215.0M |
| FCF Margin % | 12.9% | 13.9% | 20.2% |
| Return on Invested Capital (ROIC %) | 7.9% | 10.5% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $538.8M | $583.2M | — |
| Total Stockholders' Equity | $572.5M | $518.8M | — |